每周新鲜药闻,百诚与您共同关注!【药闻医讯一周速览】国家药监局药审中心关于发布《创新药研发中涉及适老化设计时的一般原则及考虑要点(试行)》的通告(2025年第45号);10亿美元!荃信生物TSLP/IL-33双抗出海;礼来携手英伟达,剑指AI……政策简报国家药监局药审中心关于发布《老年人群参与创新药临床试验的关键要素及试验设计要点(试行)》的通告(2025年第44号)10月29日,按照...
Source Link每周新鲜药闻,百诚与您共同关注!【药闻医讯一周速览】国家药监局药审中心关于发布《创新药研发中涉及适老化设计时的一般原则及考虑要点(试行)》的通告(2025年第45号);10亿美元!荃信生物TSLP/IL-33双抗出海;礼来携手英伟达,剑指AI……政策简报国家药监局药审中心关于发布《老年人群参与创新药临床试验的关键要素及试验设计要点(试行)》的通告(2025年第44号)10月29日,按照...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.